Literature DB >> 19644015

Tumorigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma.

Tomofumi Oda1, Tian Tian, Masayoshi Inoue, Jun-Ichiro Ikeda, Ying Qiu, Meinoshin Okumura, Katsuyuki Aozasa, Eiichi Morii.   

Abstract

Cancer stem cells are a limited population of tumor cells that are thought to reconstitute whole tumors. The Hoechst dye exclusion assay revealed that tumors are composed of both a main population and a side population of cells, which are rich in cancer stem cells. NR0B1 is an orphan nuclear receptor that is expressed to a greater extent in the side population, as compared with the main population, of a lung adenocarcinoma cell line. In this study, we investigated the role of NR0B1 in lung adenocarcinoma cells. Reduction of NR0B1 expression levels in lung adenocarcinoma cell lines resulted in vulnerability to anti-cancer drugs and decreased abilities for invasion, in vitro colony formation, and tumorigenicity in non-obese diabetic/severe compromised immunodeficient mice. When 193 cases of lung adenocarcinoma were immunohistochemically examined, higher levels of NR0B1 expression correlated with higher rates of lymph node metastasis and recurrence. Multivariate analysis revealed high NR0B1 expression levels, stage of the disease, and size of tumor to be independent unfavorable prognostic factors for overall and disease-free survival rates. In clinical samples, NR0B1 expression levels inversely correlated to the proportion of methylated CpG sequences around the transcription initiation site of the NR0B1 gene, suggesting the epigenetic control of NR0B1 transcription in lung adenocarcinoma. In conclusion, NR0B1 might play a role in the malignant potential of lung adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19644015      PMCID: PMC2731142          DOI: 10.2353/ajpath.2009.090010

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  A QUANTITATIVE ASSAY FOR THE NUMBER OF MURINE LYMPHOMA CELLS CAPABLE OF PROLIFERATION IN VIVO.

Authors:  W R BRUCE; H VAN DER GAAG
Journal:  Nature       Date:  1963-07-06       Impact factor: 49.962

2.  Genomic sequence of the DAX1 gene: an orphan nuclear receptor responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism.

Authors:  W Guo; T P Burris; Y H Zhang; B L Huang; J Mason; K C Copeland; S R Kupfer; R A Pagon; E R McCabe
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

3.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.

Authors:  D Bonnet; J E Dick
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

4.  Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.

Authors:  S M Hewitt; S Hamada; T J McDonnell; F J Rauscher; G F Saunders
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

Review 5.  Tumor heterogeneity.

Authors:  G H Heppner
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

6.  Nuclear receptor DAX1 in human prostate cancer: a novel independent biological modulator.

Authors:  Yasuhiro Nakamura; Takashi Suzuki; Yoichi Arai; Hironobu Sasano
Journal:  Endocr J       Date:  2008-10-01       Impact factor: 2.349

7.  Cancer stem cells persist in many cancer cell lines.

Authors:  Takao Setoguchi; Tetsuya Taga; Toru Kondo
Journal:  Cell Cycle       Date:  2004-04-01       Impact factor: 4.534

Review 8.  New natural products in cancer chemotherapy.

Authors:  W J Slichenmyer; D D Von Hoff
Journal:  J Clin Pharmacol       Date:  1990-09       Impact factor: 3.126

9.  Identification of human brain tumour initiating cells.

Authors:  Sheila K Singh; Cynthia Hawkins; Ian D Clarke; Jeremy A Squire; Jane Bayani; Takuichiro Hide; R Mark Henkelman; Michael D Cusimano; Peter B Dirks
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

10.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.

Authors:  M A Goodell; K Brose; G Paradis; A S Conner; R C Mulligan
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  15 in total

Review 1.  Minireview: role of orphan nuclear receptors in cancer and potential as drug targets.

Authors:  Stephen Safe; Un-Ho Jin; Erik Hedrick; Alexandra Reeder; Syng-Ook Lee
Journal:  Mol Endocrinol       Date:  2013-12-02

2.  The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.

Authors:  Ryo Shibuya; Atsuji Matsuyama; Mitsuhiro Nakamoto; Eisuke Shiba; Takahiko Kasai; Masanori Hisaoka
Journal:  Virchows Arch       Date:  2014-07-17       Impact factor: 4.064

3.  Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer.

Authors:  Liron Bar-Peled; Esther K Kemper; Radu M Suciu; Ekaterina V Vinogradova; Keriann M Backus; Benjamin D Horning; Thomas A Paul; Taka-Aki Ichu; Robert U Svensson; Jose Olucha; Max W Chang; Bernard P Kok; Zhou Zhu; Nathan T Ihle; Melissa M Dix; Ping Jiang; Matthew M Hayward; Enrique Saez; Reuben J Shaw; Benjamin F Cravatt
Journal:  Cell       Date:  2017-09-28       Impact factor: 41.582

4.  DAX-1 Expression in Pediatric Rhabdomyosarcomas: Another Immunohistochemical Marker Useful in the Diagnosis of Translocation Positive Alveolar Rhabdomyosarcoma.

Authors:  Calogero Virgone; Enzo Lalli; Gianni Bisogno; Elena Lazzari; Josep Roma; Angelica Zin; Elena Poli; Giovanni Cecchetto; Patrizia Dall'Igna; Rita Alaggio
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

5.  DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/β-catenin pathway via GSK3β.

Authors:  Xiao-Fang Liu; Xue-Yuan Li; Peng-Sheng Zheng; Wen-Ting Yang
Journal:  Cell Death Dis       Date:  2018-03-01       Impact factor: 8.469

6.  Digital transcriptome profiling of normal and glioblastoma-derived neural stem cells identifies genes associated with patient survival.

Authors:  Pär G Engström; Diva Tommei; Stefan H Stricker; Christine Ender; Steven M Pollard; Paul Bertone
Journal:  Genome Med       Date:  2012-10-09       Impact factor: 11.117

7.  MicroRNA-766-3p-mediated downregulation of HNF4G inhibits proliferation in colorectal cancer cells through the PI3K/AKT pathway.

Authors:  Xin-Xin He; Shan-Shan Luo; Hai-Quan Qin; Xian-Wei Mo
Journal:  Cancer Gene Ther       Date:  2021-06-22       Impact factor: 5.854

8.  Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene.

Authors:  T Okegawa; K Ushio; M Imai; M Morimoto; T Hara
Journal:  Oncogenesis       Date:  2013-07-29       Impact factor: 7.485

9.  ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells.

Authors:  Masahide Ota; Satsuki Mochizuki; Masayuki Shimoda; Hitoshi Abe; Yuka Miyamae; Ken Ishii; Hiroshi Kimura; Yasunori Okada
Journal:  Cancer Sci       Date:  2016-03-16       Impact factor: 6.716

10.  Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells.

Authors:  Yongjie Lu; Yunqiang Liu; Shunyao Liao; Wenling Tu; Ying Shen; Yuanlong Yan; Dachang Tao; Yilu Lu; Yongxin Ma; Yuan Yang; Sizhong Zhang
Journal:  Oncotarget       Date:  2016-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.